ABSTRACT
PURPOSE: Osteopontin (OPN), osteoprotegerin (OPG) and osteocalcin (OC) are matrix glycoproteins which mediate bone mineralization; moreover, their effects on glucose/insulin homeostasis have recently been demonstrated. Higher circulating OPN and OPG levels have been associated with the presence of insulin resistance, atherosclerosis and coronary heart disease. No data are available on contextual changes of these markers in type 2 diabetes mellitus (T2DM). Therefore, aims of this study were to evaluate serum OPN, OPG and OC levels in T2DM patients and their clinical correlates. METHODS: We recruited 83 consecutive T2DM patients referring to our diabetes outpatient clinics at Sapienza, University of Rome, and 71 non-diabetic sex and age-comparable subjects as a control group. Study population underwent metabolic characterization and carotid ultrasound for intima-media thickness measurement. Plasma OPN, OPG and OC were measured by MILLIPLEX Multiplex Assays Luminex. RESULTS: T2DM patients had significantly higher circulating OPN and OPG levels than controls (14.3 ± 13.6 vs 10.6 ± 13.7 ng/ml p < 0.001, 0.70 ± 0.60 vs 0.54 ± 4.1 ng/ml, p = 0.02) while OC levels were similar in the two cohorts (6.35 ± 5.8 vs 7.80 ± 7.0 ng/ml, p = n.s). OPN and OPG positively correlated with greater systolic blood pressure (SBP) values, HOMA-IR and HOMA-ß, and with the presence of dyslipidemia and carotid atherosclerosis. The association between greater OPN and OPG levels and SBP was independent from possible confounders (both p = 0.01). CONCLUSIONS: Circulating OPN and OPG levels are increased in T2DM patients and identify a particularly unfavourable metabolic profile, mostly expressed by higher SBP. Bone peptides may represent novel markers of vascular stress and accelerated atherosclerosis in diabetes, constituting a possible tool for cardiovascular risk stratification in diabetes.
Subject(s)
Biomarkers/blood , Cardiovascular Diseases/blood , Diabetes Mellitus, Type 2/complications , Metabolic Syndrome/blood , Osteopontin/blood , Osteoprotegerin/blood , Adult , Aged , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/etiology , Case-Control Studies , Cross-Sectional Studies , Diabetes Mellitus, Type 2/blood , Female , Follow-Up Studies , Humans , Male , Metabolic Syndrome/diagnosis , Metabolic Syndrome/etiology , Metabolome , Middle Aged , Osteocalcin/blood , Prognosis , Risk FactorsABSTRACT
PURPOSE: Leptin is an adipokine which regulates appetite and energy balance through a mechanism partially mediated by neurotensin (NT) in central nervous system. Besides acting as a neurotransmitter, NT is expressed in human intestine where it promotes fat absorption and its circulating levels associate with obesity, type 2 diabetes mellitus (T2DM) and cardiovascular disease. Whether a relation exists between circulating leptin and NT levels has not been investigated yet. The aim of this study was to test the hypothesis of an association between plasma leptin and NT concentration in adults with or without T2DM. METHODS: We recruited a population of 72 subjects (M/F: 39/33; age: 49.5 ± 10.6 years; BMI: 26.5 ± 4.7 kg/m2) including individuals with T2DM (n = 32) referring to our Diabetes Outpatient Clinics, Sapienza University of Rome, and healthy controls. Study participants underwent metabolic characterization; plasma leptin was measured by MILLIPLEX, Luminex, and proneurotensin (proNT), a stable precursor of NT, by chemiluminometric sandwich immunoassay. RESULTS: Circulating median (25°-75°) leptin levels were 2.75 (1.27-4.93) ng/mL and did not differ between T2DM and non-diabetic subjects. Leptin concentration directly correlated with proNT (r = 0.41; p = 0.015); higher leptin levels were also associated with age, male gender, obesity, higher HOMA-IR, systolic blood pressure and C-reactive protein. Belonging to the highest pro-NT quartile correlated with greater leptin levels independent of age, gender and other confounders (r2 = 0.82, p = 0.02). CONCLUSIONS: Circulating leptin is associated with higher proNT levels independent of diabetes, obesity and metabolic syndrome components; besides its effects on central leptin signaling, NT may influence energy balance by modulating circulating leptin concentration likely through a mechanism involving gut fat absorption.
Subject(s)
Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/diagnosis , Leptin/blood , Neurotensin/blood , Adult , Biomarkers/blood , Cross-Sectional Studies , Female , Humans , Male , Metabolic Syndrome/blood , Metabolic Syndrome/diagnosis , Middle Aged , Obesity/blood , Obesity/diagnosisABSTRACT
AIMS: Interleukin-8 (IL-8) is a chemokine involved in systemic immunity, macrophages infiltration and activation in adipose tissue and may play a significant role in the pathogenesis of type 2 diabetes (T2D) and atherosclerosis. Aims of this study were to evaluate circulating IL-8 levels in adult patients with T2D in comparison with non-diabetic subjects and to describe clinical and biochemical correlates of IL-8 concentration. METHODS: For this cross-sectional study, we enrolled 79 consecutive T2D individuals referring to our diabetes outpatient clinics at Sapienza University of Rome, and 37 sex, age and BMI comparable non-diabetic subjects as a control group. Clinical parameters and medical history were recorded; fasting blood sampling was performed for biochemistry and for measuring serum IL-8, IL-6, TNF-α, CRP, adiponectin and 25(OH)vitamin D [25(OH)D] levels. RESULTS: Patients with T2D exhibited significantly higher serum IL-8 levels than non-diabetic subjects (69.27 ± 112.83 vs. 16.03 ± 24.27 pg/mL, p < 0.001). In diabetic patients, increased IL-8 concentration correlated with higher IL-6 (p < 0.001), TNF-α (p = 0.02), FBG (p = 0.035), HbA1c (p = 0.04) and LDL-C (p = 0.04) and with lower adiponectin (p = 0.02) and 25(OH)D (p = 0.003) concentrations. CONCLUSIONS: Patients with T2D display a marked elevation of circulating IL-8 levels which identify subjects with worse inflammatory, glycometabolic and lipid profile and lower vitamin D levels. Further studies are warranted for evaluating a possible role of IL-8 as a novel marker for risk stratification in T2D patients.
Subject(s)
Diabetes Mellitus, Type 2/blood , Interleukin-8/blood , Adiponectin/blood , Adult , Biomarkers/blood , Calcifediol/blood , Cross-Sectional Studies , Diabetes Mellitus, Type 2/immunology , Female , Humans , Interleukin-6/blood , Male , Middle Aged , Tumor Necrosis Factor-alpha/bloodABSTRACT
Fatty acid synthetase (FAS) is overexpressed in various tumor tissues, and its inhibition and/or malonyl-CoA accumulation have been correlated to apoptosis of tumor cells. It is widely recognized that both omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) depress FAS expression in liver, although epidemiological and experimental reports attribute antitumor properties only to omega-3 PUFA. Therefore, we investigated whether lipogenic gene expression in tumor cells is differently regulated by omega-6 and omega-3 PUFAs. Morris hepatoma 3924A cells were implanted subcutaneously in the hind legs of ACI/T rats preconditioned with high-lipid diets enriched with linoleic acid or alpha-linolenic acid. Both-high lipid diets depressed the expression of FAS and acetyl-CoA carboxylase in tumor tissue, this effect correlating with a decrease in the mRNA level of their common sterol regulatory element binding protein-1 transcription factor. Hepatoma cells grown in rats on either diet did not accumulate malonyl-CoA. Apoptosis of hepatoma cells was induced by the alpha-linolenic acid-enriched diet but not by the linoleic acid-enriched diet. Therefore, in this experimental model, apoptosis is apparently independent of the inhibition of fatty acid synthesis and of malonyl-CoA cytotoxicity. Conversely, it was observed that apoptosis induced by the alpha-linolenic acid-enriched diet correlated with a decrease in arachidonate content in hepatoma cells and decreased cyclooxygenase-2 expression.
Subject(s)
Apoptosis/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Isoenzymes/genetics , Liver Neoplasms, Experimental/pathology , Prostaglandin-Endoperoxide Synthases/genetics , alpha-Linolenic Acid/administration & dosage , Acetyl-CoA Carboxylase/genetics , Acetyl-CoA Carboxylase/metabolism , Animals , Apoptosis/genetics , CCAAT-Enhancer-Binding Proteins/genetics , Cyclooxygenase 2 , Diet , Dietary Fats, Unsaturated , Down-Regulation/genetics , Fatty Acid Synthases/genetics , Fatty Acid Synthases/metabolism , Fatty Acids, Omega-6/genetics , Fatty Acids, Omega-6/metabolism , Fatty Acids, Unsaturated/genetics , Fatty Acids, Unsaturated/metabolism , Isoenzymes/biosynthesis , Liver Neoplasms, Experimental/drug therapy , Liver Neoplasms, Experimental/genetics , Liver Neoplasms, Experimental/metabolism , Prostaglandin-Endoperoxide Synthases/biosynthesis , Rats , alpha-Linolenic Acid/metabolismABSTRACT
The hindlimb-suspended rat was used as animal model to investigate the effects induced by immobilization of the skeletal muscle in the expression of the genes encoding hepatic lipogenic enzymes. Following a 14-day period of immobilization, rats were injected intraperitoneally with radioactive acetate, and the labeling of hepatic lipids and cholesterol was evaluated 15 min after the isotope injection. The incorporation of labeled acetate in lipids and cholesterol was almost three times higher in the liver of immobilized rats than in control animals as a consequence of the enhanced transcription of the genes encoding acetyl-CoA synthase, acetyl-CoA carboxylase, fatty acid synthase, and 3-hydroxy-3-methylglutaryl-CoA reductase. The high expression of the key enzymes for fatty acid and cholesterol synthesis induced by immobilization was not paralleled by an increase of the hepatic sterol-regulatory element binding protein (SREBP)-1 and SREBP-2 mRNA content. However, the expression of the mature form of SREBP-1 and SREBP-2 was higher in the nuclear fraction of immobilized rat liver than in controls due to a significant increase of the cleavage of the native proteins. Immobilization also affected the expression of proteins involved in lipid degradation. In fact, the hepatic content of peroxisome proliferator-activated receptor-alpha (PPARalpha) mRNA and of PPARalpha target genes encoding carnitine palmitoyl transferase-1 and acyl-CoA oxidase were significantly increased upon immobilization.
Subject(s)
Immobilization/physiology , Lipids/biosynthesis , Liver/enzymology , Acetates/metabolism , Animals , CCAAT-Enhancer-Binding Proteins/analysis , Cholesterol/biosynthesis , DNA-Binding Proteins/analysis , Enzymes/genetics , Lipids/analysis , Liver/chemistry , Male , Models, Animal , RNA, Messenger/analysis , Rats , Rats, Wistar , Sterol Regulatory Element Binding Protein 1 , Transcription Factors/analysisABSTRACT
In the treatment of peripheral obliterating arteriopathy (POA) physical training provides clear results in terms of increased walking autonomy; it is still not fully clear whether the positive effects of physical training can be further improved by concomitant back-up drug therapy. For this purpose 374 patients of both sexes, with a mean age of 64 years, suffering from chronic peripheral obliterating arteriopathy of the lower limbs were enrolled in a controlled open clinical trial, instructed to follow a programme of physical training and randomly allocated to low dose treatment with heparin calcium (12,500 IU/day) for 6 months. An improvement in the claudicometric parameters (free gait interval, absolute gait interval and recovery time) measured at constant speed and in the resting Winsor ankle/arm index of the most severely damaged limb were observed in both groups. These improvements were significantly greater in the group receiving pharmacological treatment (p < 0.01) and efficacy increased in line with basal deambulatory impairment. The results obtained and the good tolerance of the drug underline the clinical efficacy of heparin calcium at low doses in association with a physical training programme in patients suffering from Fontaine's stage II peripheral obliterating arteriopathy.
Subject(s)
Arterial Occlusive Diseases/therapy , Exercise Therapy , Fibrinolytic Agents/administration & dosage , Heparin/administration & dosage , Intermittent Claudication/therapy , Analysis of Variance , Chronic Disease , Exercise Therapy/methods , Exercise Therapy/statistics & numerical data , Female , Humans , Male , Middle Aged , Statistics, NonparametricABSTRACT
Este trabalho tem como finalidade rever a etiologia da diarréia, e no qual pesquisamos todos os agentes da infecçäo intestinal, relacionados a seguir: E. coli enteropatogênica clássica (EPEC), E.coli enteroinvasora (EIEC), E.coli enterotoxigênica (ETEC), E.coli enterohemorrágica (EHEC), Shigella, Salmonella, Yersinia enterocolítica, Campylobacter, Aeromonas e Vibriocholerae
Subject(s)
Humans , Diarrhea/etiology , Dysentery, Bacillary/microbiology , Campylobacter Infections/microbiology , Escherichia coli Infections/microbiology , Intestinal Diseases, Parasitic , Cross-Sectional Studies , Rotavirus Infections/microbiologySubject(s)
Aortic Diseases/veterinary , Aortic Valve/pathology , Blood Vessel Prosthesis/veterinary , Swine Diseases/pathology , Animals , Aortic Diseases/etiology , Aortic Diseases/pathology , Aortic Valve/surgery , Bioprosthesis , Blood Vessel Prosthesis/adverse effects , Humans , Swine , Swine Diseases/etiologyABSTRACT
The Authors examine the functional, toxicological and pharmacological controls routinely performed on materials and on the finished products. They propose a biocompatibility protocol for screening materials, and they compare Italian regulations on quality control and good manufacturing practice of medical devices with foreign regulations.
Subject(s)
Pacemaker, Artificial/standards , Biocompatible Materials , Electrodes/standards , Humans , Italy , Quality Control , United StatesABSTRACT
The natural aortic and pulmonary artery valves can be saved with excision of the ventricles and inflow valves. These valves remain functional and unaltered with implantation of an artificial heart, when pumped for 96 and 122 days. The capacity of the artificial heart to meet the physiological needs of the animal, during exercise and body growth, over 3 and 4 mos has been documented. All of the parameters monitored in 2 experiments for 3 mos (and continuing) and 4 mos clearly demonstrates the efficacy of meeting the cardiac needs with an artificial heart.
Subject(s)
Aortic Valve , Heart, Artificial , Pulmonary Valve , Animals , Aortic Valve/physiology , Autopsy , Blood Cell Count , Blood Chemical Analysis , Cattle , Male , Oxygen Consumption , Physical Exertion , Platelet Aggregation , Pulmonary Artery/physiology , Pulmonary Valve/physiology , SheepABSTRACT
Laryngeal paralysis is reported in 2 dogs which showed symptoms of dispnoea at rest, and also choking and vomiting after short exercise. Surgical removal of the mucosa of the lateral ventricles resulted in restoration of normal function and resumption of the animals' normal activities.